COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Press Release: Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma
Sanofi's Sarclisa subcutaneous formulation approved in Japan for multiple myeloma patients, offering a convenient treatment option via OBI administration and manual injection -
-
-
COMMUNIQUÉ DE PRESSE
Communiqué de presse : Sanofi et HEC Paris lancent la « Sanofi MBA Life Sciences Scholarship » pour accompagner les futurs leaders de la santé
Sanofi et HEC Paris lancent la 'Sanofi MBA Life Sciences Scholarship' pour soutenir les futurs leaders de la santé. Programme de bourses pour le MBA HEC Paris -
-
-
COMMUNIQUÉ DE PRESSE
Press Release: Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1 diabetes
Sanofi's Tzield receives US FDA approval as first disease-modifying therapy for stage 3 type 1 diabetes, targeting autoimmune attack against insulin-producing beta cells -
-
